#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leiomyosarcoma recurrent Congenital growth hormone deficiency Fibrodysplasia ossificans progressiva Small intestine leiomyosarcoma Angiosarcoma recurrent Trigeminal neuralgia Congenital pseudarthrosis Medulloblastoma Thrombocytosis Extra-osseous Ewing's sarcoma recurrent Optic glioma Chordoma Idiopathic pulmonary fibrosis Mucous membrane pemphigoid Plasma cell myeloma recurrent More trials…

    Learn about Rare Diseases

    Methylmalonic acidaemia – Basic Information Glycogen storage disease type II – Diagnostics Pituitary-dependent Cushing’s syndrome – Treatment Behcet’s syndrome – Treatment Osteosarcoma – Treatment Chondrosarcoma – Trials in Disease Atypical haemolytic uraemic syndrome – Diagnostics Systemic sclerosis pulmonary Chronic granulomatous disease – Life with Disease Adrenocortical carcinoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vidutolimod Sodium Phosphate Dodecahydrate Xaluritamig Acetylcysteine Temocillin Sodium Anhydrous Docetaxel Paroxetine Mosunetuzumab Bi 1015550 Atenolol Floxuridine Imsidolimab Tolcapone Vsf1.01 Testosterone Undecanoate Selatogrel Azd5462 Carboplatin Disodium Levofolinate 11902A More therapies…

    Learn about Your Condition

    Glioblastoma Nephrolithiasis Acquired haemophilia Poor quality sleep Thyroid mass Tuberculosis Acute promyelocytic leukaemia Genital herpes Neonatal asphyxia Foetal growth restriction Haemorrhage Optic ischaemic neuropathy Schizophrenia Binge eating Meningorrhagia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immune system processes

  • Maribavir for High Epstein-Barr Virus Infection in Young Adult Kidney Transplant Recipients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Epstein-Barr virus infection
    Investigated Drugs:
    • Maribavir
    Spain

  • Study of Tenofovir Alafenamide as Add-on Treatment to Anti-CD20 Therapy in Multiple Sclerosis Patients to Reduce Neuronal Damage

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Tenofovir Alafenamide
    Norway

  • Study on Early Measles Immunization with MMR-0 Vaccine for Infants Under 12 Months During a Measles Outbreak

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Measles Virus Edmonston-Enders Strain (Live, Attenuated) Produced In Chick Embryo Cells
    • Mumps Virus Jeryl Lynn (Level B) Strain (Live, Attenuated) Produced In Chick Embryo Cells
    • N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
    The Netherlands

  • Study on COVID-19 Immunity in Immunocompromised Adults Using Raxtozinameran and Bretovameran in Belgium

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Raxtozinameran
    Belgium

  • Study on the Best Timing for Pertussis Vaccination in Pregnant Women Using Diphtheria, Tetanus, and Pertussis Vaccine

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • TETANUS TOXOID
    Belgium

  • Study on the Safety and Effectiveness of Tacrolimus and Drug Combination for Patients with BK Polyomavirus Infection After Kidney Transplantation

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Azathioprine
    • Sirolimus
    • Belatacept
    Germany
Previous Page
1 … 3 4 5 6 7 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!